(no subject)

From mailnull@flowcyt.cyto.purdue.edu Fri Aug 24 20:50:57 2007
Received: from flowcyt.cyto.purdue.edu (localhost.cyto.purdue.edu [127.0.0.1])
	by flowcyt.cyto.purdue.edu (8.12.10/8.12.10) with ESMTP id l7P0ot5A098864
	for <cytolist@flowcyt.cyto.purdue.edu>; Fri, 24 Aug 2007 20:50:55 -0400 (EDT)
	(envelope-from mailnull@flowcyt.cyto.purdue.edu)
Received: (from mailnull@localhost)
	by flowcyt.cyto.purdue.edu (8.12.10/8.12.10/Submit) id l7P0otoh098863
	for cytolist; Fri, 24 Aug 2007 20:50:55 -0400 (EDT)
	(envelope-from mailnull)
Received: from [192.168.1.102] (74-140-113-147.dhcp.insightbb.com [74.140.113.147])
	(authenticated bits=0)
	by flowcyt.cyto.purdue.edu (8.12.10/8.12.10) with ESMTP id l7P0oq2a098857;
	Fri, 24 Aug 2007 20:50:52 -0400 (EDT)
	(envelope-from jpr@flowcyt.cyto.purdue.edu)
Message-ID: <46CF7CEA.6070306@flowcyt.cyto.purdue.edu>
Date: Fri, 24 Aug 2007 20:50:50 -0400
From: "J. Paul Robinson" <jpr@flowcyt.cyto.purdue.edu>
Organization: Purdue University
User-Agent: Thunderbird 2.0.0.6 (Windows/20070728)
MIME-Version: 1.0
To: Cytometry Mailing List <cytometry@flowcyt.cyto.purdue.edu>
Subject: Re: Immunotherapy with antibody - Clarification - buyer beware!!
References: <I-7-885395-37898051-2-11211-US1-692BF5D0@xmr3.com> <8C9B4143D51E2D9-7A4-1D87@mblk-r29.sysops.aol.com>
In-Reply-To: <8C9B4143D51E2D9-7A4-1D87@mblk-r29.sysops.aol.com>
Content-Type: text/plain; charset=UTF-8; format=flowed
Content-Transfer-Encoding: 8bit
X-Spam-Score: -4.9 () BAYES_00
X-Scanned-By: MIMEDefang 2.39
X-PMFLAGS: 34078848 0 1 98869.cnm                           

Just in case there is any question about these organizations like IBC 
and CHI ...

.they are businesses whose primary role is in making money...a lot of 
money....I have been invited to each of these organizations to speak in 
the past.......my gut feeling is that they over charge, the quality of 
the meetings is not something that I would be positive about and I would 
be very cautious about seeing these organizations as in any way 
representing the status of a scientific discipline.

My advice is to focus on a scientific conference run by scientific 
societies....not a commercial entity....

Sometimes reading the books is better....and a whole lot cheaper. 
Frankly, I don't think much of the quality of these conferences at all....

regards

Paul Robinson



rozenkov@netscape.net wrote:
> Meixia,
> The two conferences below should answer all your questions...
> Otherwise, you need to read many thick books...
> Regards.
> 
> Vladislav Rozenkov
> 
> P.S. disclaimer: Not that I am going to go to those conferences or 
> promoting them.
> 
> 
> -----Original Message-----
> From: Meixia Zhang <meixia_zhang@yahoo.com>
> To: cyto-inbox Sent: Wed, 22 Aug 2007 9:23 am
> Subject: Immunotherapy with antibody
> 
> Dear All,
>  
> This is not FACS related question, but I need your ideas.
>  
> Nowadays immunotherapy is the fourth means for cancer therapy. There are 
> more and more monoclonal antibodies which are effective in treating 
> tumors, like Rituximab, Avastin and Herceptin. Now my questions are:
>  
> 
>    1. Which kinds of antibodies have therapeutic effects? (except the
>	knowing Abs likeRituximab, Avastin and Herceptin,  in most cases
>	monoclonal Ab by themselves are not cytotoxic. For example,
>	antibody against mesothelin – a differentiation antigen which is
>	overexpressed on ovarian cancer and malignant mesothelioma does
>	not have cytotoxic effect. )
>    2. What do cytotoxic effects of antibody depend on? (the structure of
>	antigen or antibody or the tumor types or the location of the
>	antigen?)
>    3. How to judge whether an antibody will have immunotherapeutic
>	features?  
> 
>  
> Best Regards
>  
> Meixia
> 
> 

> 
> Dear Vladislav,
>  
> We are excited to announce IBC’s 5^th Annual International Antibody 
> Therapeutics conference.  Look for the brochure -
> it should be arriving in your mailbox any day now.  We couldn’t hold 
> back any longer so here’s a *_sneak preview_* –
> *Download Brochure 
>
<http://pull.xmr3.com/p/12033-970C/20734066/clickto1_fesciences.com-D4173-8076.xml.html>*
. 
> 

>  
ail virus protection.


-- 
J. Paul Robinson
SVM Professor of Cytomics
Professor of Immunopharmacology & Biomedical Engineering
Director, Purdue University Cytometry Laboratories
President, International Society for Analytical Cytology

Purdue University Cytometry Laboratories
Bindley Bioscience Center
1203 West State Street
Discovery Park, Purdue University
West Lafayette, IN 47907-2057
Ph (765) 494 0757; Fax (765) 494 0517
email: jpr@flowcyt.cyto.purdue.edu
www.cyto.purdue.edu

Join ISAC - www.isac-net.org

Change lives today  - www.cytometryforlife.org